Reactions Weekly

, Volume 1695, Issue 1, pp 171–171 | Cite as

Erlotinib

Hepatotoxicity: case report
Case report
  • 9 Downloads

Reference

  1. Endo-Tsukude C, et al. Population pharmacokinetics and adverse events of erlotinib in Japanese patients with non-small-cell lung cancer: Impact of genetic polymorphisms in metabolizing enzymes and transporters. Biological and Pharmaceutical Bulletin 41: 47-56, No. 1, Jan 2018 - JapanCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations